Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
30.55
-0.03 (-0.10%)
Oct 13, 2026, 4:00 PM EDT - Market closed
Doximity Revenue
Doximity had revenue of $156.62M in the quarter ending June 30, 2026, with 7.34% growth. This brings the company's revenue in the last twelve months to $655.57M, up 11.18% year-over-year. In the fiscal year ending March 31, 2026, Doximity had annual revenue of $644.86M with 13.05% growth. That makes Doximity the 9,688th largest company in the world by revenue and 2,117th in the United States.
Revenue (ttm)
$655.57M
Revenue Growth
+11.18%
P/S Ratio
8.31
Revenue / Employee
$744,964
Employees
880
Market Cap
5.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 644.86M | 74.46M | 13.05% |
| Mar 31, 2025 | 570.40M | 94.98M | 19.98% |
| Mar 31, 2024 | 475.42M | 56.37M | 13.45% |
| Mar 31, 2023 | 419.05M | 75.50M | 21.98% |
| Mar 31, 2022 | 343.55M | 136.65M | 66.05% |
| Mar 31, 2021 | 206.90M | 90.51M | 77.76% |
| Mar 31, 2020 | 116.39M | 30.69M | 35.82% |
| Mar 31, 2019 | 85.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 14.37B |
| Privia Health Group | 2.36B |
| Tempus AI | 1.43B |
| HealthEquity | 1.36B |
| Omnicell | 1.25B |
| Waystar Holding | 1.21B |
| Hinge Health | 720.06M |
| Certara | 421.75M |
DOCS News
- 19 hours ago - Doximity extends 13-year partnership with U.S. News & World Report - TheFly
- 1 day ago - Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors - Business Wire
- 1 day ago - Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors - PRNewsWire
- 5 days ago - Kaplan Fox Encourages Doximity, Inc. (DOCS) Investors to Contact the Firm Before the Deadline on November 16, 2026 for a Leadership Role - Newsfile Corp
- 7 days ago - Kaplan Fox Advises Doximity, Inc. (DOCS) Investors to Act Before the Lead Plaintiff Deadline on November 16, 2026 - Newsfile Corp
- 14 days ago - Doximity price target lowered to $35 from $40 at Evercore ISI - TheFly
- 15 days ago - Robbins LLP is Investigating Allegations that Doximity, Inc. Failed to Disclose to Investors it Was Losing Market Share to its Competitors With More Favorable Pricing and Engagement Models - Newsfile Corp
- 19 days ago - Kaplan Fox Reminds Doximity, Inc. (DOCS) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 16, 2026 - Newsfile Corp